期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血小板源生长因子受体抑制剂的研究近况 被引量：1

Recent Studies in Platelet-derived Growth Factor Receptor Inhibitors
在线阅读 下载PDF
导出
摘要 近年来的研究发现 ,酪氨酸蛋白激酶水平的升高已成为细胞增殖恶变的标志之一 ,其特异性的抑制剂对肿瘤有较高的预防及治疗价值。本文着重阐述了酪氨酸蛋白激酶受体中的血小板源生长因子受体抑制剂的作用机制、分类。 Recent studies showed that the increase of the protein tyrosine kinases level is one of the signals of the cellular proliferation and degeneration. The specific inhibition of growth related kinases,especially tyrosine kinases might provide new therapies for cancer.The present review summarizes and discusses the mechanism,classification and structure activity relationship(SAR) of one of the protein tyrosine kinases -- PDGFr inhibitors, and the related novel drugs.
作者 杜吕佩 夏霖
机构地区 中国药科大学药物化学教研室
出处 《药学进展》 CAS 2003年第1期9-15,共7页 Progress in Pharmaceutical Sciences
关键词 酪氨酸蛋白激酶 血小板源生长因子 血小板源生长因子受体制剂 Protein tyrosine kinases Platelet derived growth factor Platelet derived growth factor receptor inhibitor
分类号 R965 [医药卫生—药理学]
  • 相关文献

参考文献2

二级参考文献13

  • 1Jian L，J Nat Prod，1994年，57卷，4期，524页
  • 2Xiong F，J Nat Prod，1994年，57卷，11期，1591页
  • 3Druker JB, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells[J]. Nat Med, 1996, 2(5): 561 - 566.
  • 4Deininger MW, Goldman JM, Lydon N, et al. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells[J ]. Blood, 1997, 90, 3691 - 3698.
  • 5Garnbacoti-Passerini C, le-Coutre P, Mologni L, et al. Inhibitor of the ABL kinase activity blocks the proliferation of BCR/ABL leukemic cells and induces apoptosis [ J ]. Blood Cells Mol Dis,1997, 23: 380 - 394.
  • 6Carroll M, Ohno-Jones S, Tamura S, et al. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [ J ].Blood, 1997,90: 4947 - 4952.
  • 7Myllarniemi M, Frosen J, Ramirez LG. Selective tyrosine kinase inhibitor for platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo[J]. Cardivoasc Drugs Ther, 1999, 13:159 - 168.
  • 8Heinrich MC, Griffith DJ, Druker BJ. Inhibition of c-kti receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor[ J ]. Blood, 2000, 96: 925 - 932.
  • 9Buchdunger E, Cioffi CL, Law N. The abl protein-tyrosine kinase inhibitor, STI571, inhibits in vitro singal transduction mediated by c-Kit and PDGF receptors[J ]. J Pharmacol Ther, 2001, (inpress).
  • 10Druker BJ, Talpas M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia[J ]. N Engl J Med, 2001, 344 (14): 1031 -1037.

共引文献2

同被引文献17

  • 1李剑欣,张绪梅,徐琪寿.色氨酸的生理生化作用及其应用[J].氨基酸和生物资源,2005,27(3):58-62. 被引量：91
  • 2White R. , Jobling S, Hoare S A, Sumpter J P, Parker M G. Endocrinology,1994, 135(1) : 175-182.
  • 3Lopez-Espinosa M J, Freire C, Arrebola J P, Navea N, Taoufiki J, Fernandez M F, Ballesteros O, Prada R. Olea N. Chemosphere,2009,76(6) : 847-852.
  • 4Ying G G, Williams B, Kookana R. Environ. Int. ,2002,28(3) : 215-226.
  • 5Soares A, Guieysse B, Jefferson B, Cartmell E, Lester, J N. Environ. Int. , 2008,34(7): 1033-1049.
  • 6Sasaki K, Takatsuki S, Nemoto S, Imanaka M, Eto S, Murakami E, Toyoda M J. Food Hyg. Soc. Jpn. , 1999, 40:460-472.
  • 7Lu B, Zhan P. Toxicol Environ Chem. ,2008,90(1) : 127-143.
  • 8Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T. Environ. Sci. Technol. , 2002, 36 (8): 1676--1680.
  • 9Lu Y Y, Chen M L, Sung F C, Wang P S, Mao I F. Environ. Int. ,2007,33(7) : 903-910.
  • 10Raecker T, Thiele B, Boehme RM, Guenther K. Chemosphere,2011, 82(11) : 1533-1540.

引证文献1

二级引证文献3

药学进展
2003年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部